logo

For the Inventor, By the Inventor

Tampa, FL, United States of America

Intezyne Technologies, Incorporated


USPTO Granted Patents = 37

% Expired Patents = 21.6



Trademarks = 1

Forward Citations = 276

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal Kevin N Sill (35 out of 48 patents)

silverMedal Habib Skaff (23 out of 28 patents)

bronzeMedal Kurt Breitenkamp (19 out of 26 patents)

4.  Rebecca Breitenkamp (7 out of 7 patents)

5.  Adam Carie (5 out of 10 patents)

6.  David L Morse (4 out of 19 patents)

7.  Josef Vagner (4 out of 14 patents)

8.  Narges Tafreshi (4 out of 7 patents)

9.  Jonathan L Sessler (4 out of 89 patents)

10.  Natalie M Barkey (4 out of 4 patents)

11.  Christian Preihs (4 out of 6 patents)

12.  Victor J Hruby (4 out of 39 patents)

13.  Tomas Vojkovsky (4 out of 11 patents)

14.  Robert J Gillies (4 out of 25 patents)

15.  Janni Mirosevich (3 out of 3 patents)


Core Competencies:
Melanocortin Receptor
Polymeric Micelles
Block Copolymers
Drug Delivery
Hydrophobic Agents
Neuroendocrine Tumors
Polynucleotide Encapsulation
Hybrid Block Copolymers
Encapsulated Contrast Agents
Covalent Modification
Therapeutic Agents

37 patents:

1. 12173087 - Melanocortin 1 receptor ligands and methods of use (2024-12-24),
2. 11230568 - Melanocortin 1 receptor ligands and methods of use (2022-01-25),
3. 10857147 - SN-38 loaded iron crosslinked micelle and methods thereof (2020-12-08),
4. 10329326 - Melanocortin 1 receptor ligands and methods of use (2019-06-25),
5. 10047197 - Block copolymers for stable micelles (2018-08-14),
6. 9944754 - Block copolymers for stable micelles (2018-04-17),
7. 9944752 - Block copolymers for stable micelles (2018-04-17),
8. 9499665 - Block copolymers for stable micelles (2016-11-22),
9. 9441013 - Melanocortin 1 receptor ligands and methods of use (2016-09-13),
10. 9089578 - Method of treating neuroendocrine tumors (2015-07-28),
11. 9078930 - Block copolymers for stable micelles (2015-07-14),
12. 8980326 - Hybrid block copolymer micelles with mixed stereochemistry for encapsulation of hydrophobic agents (2015-03-17),
13. 8921111 - Polymer based polynucleotide transfection agents (2014-12-30),
14. 8779008 - Polymeric micelles for drug delivery (2014-07-15),
15. 8747904 - Polymeric micelles for polynucleotide encapsulation (2014-06-10),
Company Overview
Intezyne Technologies, Incorporated is a biotechnology firm based in Tampa, Florida, specializing in the development of innovative drug delivery systems and therapeutic solutions. The company focuses on enhancing the efficacy and safety of treatments through advanced polymer-based technologies. Intezyne's research spans various domains, including oncology and other critical therapeutic areas, aiming to improve patient outcomes by optimizing the delivery of therapeutic agents.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Intezyne Technologies, Incorporated USPTO Patent Assignee Logo
37 Patents

#18 in Tampa, FL

#216 in Florida

#9,251 in US

#18,260 in the World

Tampa, FL (US)
Tampa, FL, United States of America

Intezyne Technologies, Incorporated

Forward Citations = 276

21 inventors:

goldMedal Kevin N Sill (35 out of 48 patents)

silverMedal Habib Skaff (23 out of 28 patents)

bronzeMedal Kurt Breitenkamp (19 out of 26 patents)

4.  Rebecca Breitenkamp (7 out of 7 patents)

5.  Adam Carie (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Intezyne Technologies, Incorporated. Retrieved from https://idiyas.com/company/intezyne-technologies

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…